+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Glycogen Synthase Kinase 3 (GSK3) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Glycogen Synthase Kinase 3 (GSK3) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Polo-Like Kinase 1 (PLK1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Polo-Like Kinase 1 (PLK1) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ovarian Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Ovarian Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bruton's Tyrosine Kinase (BTK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

MAP Kinase Kinase 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
C-Raf Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

C-Raf Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Fms-like Tyrosine Kinase 3 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Fms-like Tyrosine Kinase 3 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Spleen Tyrosine Kinase (SYK) Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
DNA Gyrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

DNA Gyrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Advanced Breast Cancer In Premenopausal Women - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Breast Cancer In Premenopausal Women - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Mayus Kinase 1 (JAK1) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Matrix Metalloproteinase 9 (MMP-9) Inhibitor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Neo Antigen T-cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

Neo Antigen T-cell Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
T Cell Therapy - Pipeline Insight, 2025 - Product Thumbnail Image

T Cell Therapy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Ovarian Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Ovarian Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 210 Pages
  • Global
From
ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more